SECURITY INTEREST AGREEMENTSecurity Interest Agreement • December 7th, 2007 • Millennium Biotechnologies Group Inc • Pharmaceutical preparations • New York
Contract Type FiledDecember 7th, 2007 Company Industry JurisdictionSECURITY INTEREST AGREEMENT ("Security Interest Agreement"), dated as of November 30, 2007, by and between HARBORVIEW MASTER FUND LP (the “Secured Party”), with headquarters c/o Navigator Management Ltd., Harbour House, 2d Floor, Road Town, Tortola, BVI and MILLENNIUM BIOTECHNOLOGIES, INC., a Delaware corporation with headquarters located at 665 Martinsville Road, Suite 219, Basking Ridge, NJ 07920 (the “Company” or the “Debtor”).
SECURITY INTEREST AGREEMENTSecurity Interest Agreement • December 7th, 2007 • Millennium Biotechnologies Group Inc • Pharmaceutical preparations • New York
Contract Type FiledDecember 7th, 2007 Company Industry JurisdictionThe undersigned, MILLENNIUM BIOTECHNOLOGIES, INC. (“Millennium” or “Debtor”), a Delaware corporation with headquarters located at 665 Martinsville Road, Suite 219, Basking Ridge, NJ, for value received, hereby grants unto
ContractSecured Convertible Note • December 7th, 2007 • Millennium Biotechnologies Group Inc • Pharmaceutical preparations • New York
Contract Type FiledDecember 7th, 2007 Company Industry JurisdictionTHIS NOTE AND THE COMMON SHARES ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS NOTE AND THE COMMON SHARES ISSUABLE UPON CONVERSION OF THIS NOTE MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS NOTE UNDER SAID ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO MILLENNIUM BIOTECHNOLOGIES GROUP, INC. THAT SUCH REGISTRATION IS NOT REQUIRED.
LOAN AGREEMENTLoan Agreement • December 7th, 2007 • Millennium Biotechnologies Group Inc • Pharmaceutical preparations • New York
Contract Type FiledDecember 7th, 2007 Company Industry JurisdictionTHIS LOAN AGREEMENT, dated as of November 30, 2007, is entered into by and between MILLENNIUM BIOTECHNOLOGIES GROUP, INC., a Delaware corporation with headquarters located at 665 Martinsville Road, Suite 219, Basking Ridge, NJ 07920 (the “Company”), and HARBORVIEW MASTER FUND L.P., c/o Beacon Capital Management, Harbor House, Roadtown, Tortola, BVI (the “Buyer”).